Samaritan Gets AMEX Compliance Warning
13th Nov 2006, 20:17 GMT
Biopharmaceutical company Samaritan Pharmaceuticals said it got a notice from the American Stock Exchange saying it did not meet listing standards Samaritan said it did not comply with Amex rules requiring companies to have shareholder equity of not less than $4 mln and losses from continuing operations, or net losses, in 3 out of 4 of its most recent FYE s as well as a rule requiring shareholder equity of not less than $6 mln and net losses in the 5 most recent FYE s.
Samaritan Gets AMEX Compliance Warning related news:
- Samaritan Receives AMEX Compliance Notice Letter — ArriveNet : Business
- Samaritan Arrives at Definitive Agreement to Acquire Metastatin to Expand Cancer Pipeline — ArriveNet : Press Releases
- Transnational Financial Receives Notice of Extension to Regain Compliance With AMEX Listing Standards — DBusiness News - San Francisco
- QUMAS: Compliance Risk Equates to Brand Risk -- Savvy Financial Services Firms are Incorporating Compliance Risk Into Mainstream Risk Management — ArriveNet : Technology
- ECM, Not Just Compliance — BIOS Opinions: The Quality Tech Guide
- QUMAS: QUMAS: Compliance Risk Equates to Brand Risk -- Savvy Financial Services Firms are Incorporating Compliance Risk Into Mainstream Risk Management — Market Wire - Computers and Software
- LogLogic Makes Case for Forensics and Continuous Compliance Strategies With Log Intelligence — ArriveNet : Technology
- AHA: Attention from Pharmacist Improves Compliance for Older Patients — MedPage Today Cardiovascular
- LogLogic: LogLogic Makes Case for Forensics and Continuous Compliance Strategies With Log Intelligence — Market Wire - Financial Services
- MetricStream, Inc.: MetricStream Announces ComplianceOnline.com — Market Wire - Computers and Software
Latest news from Financial News News from StratCenter.com:
- TRADE NEWS: Agilent Technologies Introduces High-Speed, High-Volume USB Multifunction Data Acquisition Modules, Chassis
- Bio-Rad Closes Buy of Ciphergen Unit
- The LGL Group Reports Q3 Earnings
- Analogic CEO to retire
- Analogic CEO Plans to Retire
- Meade Instruments Contracts with Leading Asian Outsource Manufacturing Firm
- JMAR Receives Nasdaq Delisting Notice
- Analogic Corp Announces Mgmt Changes
- Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems
- Agilent to buy Switzerland's Acqiris